CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
NanHua Bio-medicine Co Ltd Company Snapshot
NanHua Bio-medicine Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares NanHua Bio-medicine Co Ltd with three other miscellaneous service companies in Asia: NatureCell Co Ltd of KOREA (SOUTH) (2019 sales of 23.07 billion Korean Won [US$20.21 million] of which 59% was Stem Cells), Peptidream Inc of JAPAN (2.07 billion Japanese Yen [US$19.71 million] of which 100% was Alliance), and Sunmax Biotechnology Co Limited which is based in TAIWAN (594.15 million Taiwanese Dollars [US$20.66 million] of which 84% was China Mainland).

Sales Analysis. NanHua Bio-medicine Co Ltd reported sales of 133.79 million Chinese Renmimbi (US$19.98 million) for the year ending December of 2019. This represents an increase of 41.2% versus 2018, when the company's sales were 94.79 million Chinese Renmimbi. This was the fourth straight year of sales growth at NanHua Bio-medicine Co Ltd. Sales of Human Cell Detection and Storage saw an increase that was more than double the company's growth rate: sales were up 172.8% in 2019, from 18.84 million Chinese Renmimbi to 51.40 million Chinese Renmimbi. NanHua Bio-medicine Co Ltd also saw significant increases in sales in Other Business (up 54.7% to 5.90 million Chinese Renmimbi) . Not all segments of NanHua Bio-medicine Co Ltd experienced an increase in sales in 2019: sales of Other fell 17.7% to 200,630.75 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). NanHua Bio-medicine Co Ltd also experienced decreases in sales in Monoclonal Antibody Sales and Services (down 10.4% to 41.88 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
NanHua Bio-medicine Co Ltd
  Stock Performance Chart for NanHua Bio-medicine Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 13.77
(Figures in Chinese Renmimbi)
1 Week -2.9%   13 Weeks -4.8%  
4 Weeks 3.9%   52 Weeks 57.6%  
 
NanHua Bio-medicine Co Ltd Key Data:
  Ticker: 000504 Country: China
  Exchanges: SZN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 133,793,605
(Year Ending Jan 2020).
Employees: 351
  Currency: Chinese Renmimbi Market Cap: 4,290,372,617
  Fiscal Yr Ends: December Shares Outstanding: 311,573,901
  Share Type: A Gu Closely Held Shares: 163,924,285
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.